P927: Long-term outcomes of risankizumab in Crohn’s disease: a multicenter GETAID StudyECCO'24Year: 2024
Authors: Fumery, M.(1)*;Caron, B.(2);Hébuterne, X.(3);Altwegg, R.(4);Roblin, X.(5);Stefanescu, C.(6);Meyer, A.(7);Nachury, M.(8);Laharie, D.(9);Le Berre, C.(10);Guillo, L.(11);Biron, A.(12);Caillo, L.(13);Buisson, A.(14);Nancey, S.(15);Uzzan, M.(16);Vuitton, L.(17);Gilletta, C.(18);Geyl, S.(19);Simon, M.(20);Kirchgesner, J.(21);Ah Soune, P.(22);Duveau, N.(23);Vidon, M.(24);Abitbol, V.(25);Paupard, T.(26);Defrance, A.(27);Peyrin-Biroulet, L.(2);
(1)Amiens University Hospital, Gastroenterology, Amiens Cedex 1, France;(2)Nancy University Hospital, Gastroenterology, Nancy, France;(3)Nice University Hospital, Gastroenterology, Nice, France;(4)Montpellier University Hospital, Gastroenterology, Amiens, France;(5)Saint-Etienne University Hospital, Gastroenterology, Saint-Etienne, France;(6)Institut des MICI, Gastroenterology, Neuilly-sur-Seine, France;(7)Kremlin-Bicêtre, Gastroenterology, Kremlin-Bicêtre, France;(8)Lille University Hospital, Gastroenterology, Lille, France;(9)Bordeaux University Hospital, Gastroenterology, Bordeaux, France;(10)Nantes University Hospital, Gastroenterology, Nantes, France;(11)Marseille University Hospital, Gastroenterology, Marseille, France;(12)Reims University Hospital, Gastroenterology, Reims, France;(13)Nîmes University Hospital, Gastroenterology, Nîmes, France;(14)Clermont-Ferrand University Hospital, Gastroenterology, Clermont-Ferrand, France;(15)Lyon University Hospital, Gastroenterology, Lyon, France;(16)Creteil University Hospital, Gastroenterology, Creteil, France;(17)Besancon Uniiversity Hospital, Gastroenterology, Besancon, France;(18)Toulouse University Hospital, Gastroenterology, Toulouse, France;(19)Limoges University Hospital, Gastroenterology, Limoges, France;(20)Institut Montsouris, Gastroenterology, Paris, France;(21)Saint-Antoine Hospital, Gastroenterology, Paris, France;(22)Toulon Hospital, Gastroenterology, Toulon, France;(23)Roubaix Hospital, Gastroenterology, Roubaix, France;(24)Creteil Centre Hospitalier, Gastroenterology, Creteil, France;(25)Cochin Hospital, Gastroenterology, Paris, France;(26)Dunkerque Hospital, Gastroenterology, Dunkerque, France;(27)GETAID, getaid, Paris, France;GETAID
P928: @D@Metabolism and Response to Stress@D@ (MARS) gene signatures reveal heterogeneity in patients with Ulcerative Colitis and identify characteristics of patients with increased response to therapyECCO'24Year: 2024
Authors: Linggi, B.(1)*;Sangiorgi, B.(1);Smith, M.I.(1);Teft, W.(1);Jairath, V.(1,2,3);Ma, C.(1,4,5);Vande Casteele, N.(1,6);
(1)Alimentiv Inc., Medical R&D, London, Canada;(2)Western University, Department of Medicine- Division of Gastroenterology, London, Canada;(3)Western University, Department of Epidemiology and Biostatistics, London, Canada;(4)University of Calgary, Division of Gastroenterology & Hepatology- Cumming School of Medicine, Calgary, Canada;(5)University of Calgary, Department of Community Health Sciences- Cumming School of Medicine, Calgary, Canada;(6)University of California San Diego, Department of Medicine, La Jolla, United States;
P929: Relation between Crohn’s disease phenotype and response to ustekinumab in Stockholm – the STOCUSTE studyECCO'24Year: 2024
Authors: Bello, F.(1)*;Muhsen, S.(2);Sabhan, H.(3);Borin, A.(4);Johansson, F.(5);Höög, C.(6);Forsberg, O.(7);Wennerström, C.(8);Söderman, C.(9);Lördal, M.(2);Almer, S.(10);
(1)Karolinska Institutet and Karolinska University Hospital, Department of Medicine Solna KI and Division of Gastroenterology, Stockholm, Sweden;(2)Danderyd Hospital, Division of Gastroenterology and Hepatology- Department of Medicine, Stockholm, Sweden;(3)S:t Göran’s Hospital, Gastroenterology Unit- Medical Department, Stockholm, Sweden;(4)South Hospital, Department of Medicine, Stockholm, Sweden;(5)Danderyd Hospital, Medical Library, Stockholm, Sweden;(6)Karolinska Institutet and Karolinska University Hospital, Department of Medicine Huddinge KI and of Upper Digestive Diseases, Stockholm, Sweden;(7)Janssen Cilag AB, Gastroenterology, Stockholm, Sweden;(8)Janssen Cilag AB, Medical epidemiology, Stockholm, Sweden;(9)Karolinska Institutet and S:t Göran’s Hospital, Medicine Solna KI and Gastroenterology Unit Medical department, Stockholm, Sweden;(10)Karolinska Institutet and Karolinska University Hospital, Department of Medicine Solna KI and Division of Gastroenterology, Stockholm, Sweden;
P930: Rapid symptomatic improvement with subcutaneous infliximab induction treatment for patients with moderate-to-severe Crohn’s disease: first results from the DIRECT-CD studyECCO'24Year: 2024
Authors: AnjieMD, S.(1)*;Jharap, B.(2);Jansen, J.M.(3);Mares, W.G.(4);Duijvestein, M.(5);Maljaars, J.P.W.(6);Oldenburg, B.(7);D@E@Haens, G.R.A.M.(1);Gecse, K.B.(1);
(1)Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Meander MC, Department of Gastroenterology and Hepatology, Amersfoort, The Netherlands;(3)OLVG, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(4)Ziekenhuis Gelderse Vallei, Department of Gastroenterology and Hepatology, Ede, The Netherlands;(5)Radboudumc, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(6)LUMC, Department of Gastroenterology and Hepatology, Leiden, The Netherlands;(7)UMC Utrecht, Department of Gastroenterology and Hepatology, Utrecht, The Netherlands;On behalf of the Initiative on Crohn and Colitis (ICC)
P931: Burden of disease among Ulcerative Colitis patients with isolated proctitis in the United States and EuropeECCO'24Year: 2024
Authors: Armuzzi, A.(1)*;Danese, S.(2);Barreiro-de Acosta, M.(3);Hur, P.(4);Bartolome, L.(4);Wosik, K.(5);Knight, H.(6);Palace, V.(6);Peyrin-Biroulet, L.(7);
(1)IRCCS Humanitas Research Hospital, IBD Unit, Milan, Italy;(2)IRCCS San Raffaele Hospital and Vita Salute San Raffaele University, Division of Gastroenterology and Endoscopy, Milan, Italy;(3)University Hospital of Santiago de Compostela, IBD Unit, A Coruña, Spain;(4)Pfizer Inc, Global Health Economics and Outcomes - Inflammation & Immunology, New York, United States;(5)Pfizer Canada Inc, Gastroenterology- Inflammation and Immunology, Kirkland, Canada;(6)Adelphi Real World, Autoimmune Franchise, Bollington, United Kingdom;(7)Nancy University Hospital, Department of Gastroenterology, Vandœuvre-lès-Nancy, France;
P932: Corticosteroid-sparing effect of mirikizumab for the treatment of moderately-to-severely active Ulcerative Colitis: Extended induction subgroup analysis from Phase 3 trialECCO'24Year: 2024
Authors: Laharie, D.(1)*;Siegel, C.(2);Dulai, P.(3);Matsuoka, K.(4);Gisbert, J.(5);Samaan, K.(6);Redondo, I.(6);Baygani, S.(6);Paulissen, J.(7);Jairath, V.(8);
(1)Hôpital Haut-Lévêque- Centre Hospitalier Universitaire de Bordeaux, Gastroenterology, Bordeaux, France;(2)Dartmouth-Hitchcock Medical Center, Gastroenterology and Hepatology, Lebanon, United States;(3)Northwestern Medicine Digestive Health Center, Gastroenterology, Chicago, United States;(4)Tokyo Medical and Dental University, Gastroenterology and Hepatology, Tokyo, Japan;(5)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa [IIS-Princesa]- Universidad Autónoma de Madrid- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas [CIBEREHD], Gastroenterology, Madrid, Spain;(6)Eli Lilly and Company, Immunology, Indianapolis, United States;(7)Syneos Health, Immunology, Morrisville, United States;(8)Western University, Gastroenterology, London, Canada;
P933: Closing the internal opening with a rectal advancement flap increases the effectiveness of mesenchymal stem cell (MSC) injection in the treatment of complex Crohn@E@s disease anal fistulasECCO'24Year: 2024
Authors: Fathallah, N.(1)*;O@E@Neill, C.(2);Haouari, M.A.(3);Barré, A.(1);Roland, D.(1);Alam, A.(1);Kassouri, L.(1);Safa Far, E.(1);Spindler, L.(1);de Parades, V.(1);
(1)GH Paris Saint-Joseph, Proctology, Paris, France;(2)Centro Hospitalar de Lisboa Ocidental-Hospital de Egas Moniz, Gastroenterology, Lisboa, Portugal;(3)GH Paris Saint-Joseph, Radiology, Paris, France;
P934: A delphi consensus on the optimisation of medical and surgical therapy in perianal fistulising Crohn’s disease, targeted at individual TOpCLASS classification groupsECCO'24Year: 2024
Authors: Hanna, L.(1)*;Anandabaskaran, S.(2);Iqbal, N.(3);Geldof, J.(4);LeBlanc, J.F.(5);Dige, A.(6);Lundby, L.(7);Bislenghi, G.(8);Verstockt, B.(9);D@E@Hoore, A.(8);Vermeire, S.(9);De Looze, D.(4);Lobaton, T.(4);Van de Putte, D.(10);De Kock, I.(11);Carvello, M.(12);Spinelli, A.(12);Danese, S.(13);Buskens, C.J.(14);Gecse, K.(15);Hompes, R.(14);van der Bilt, J.D.W.(14);Bemelman, W.A.(14);Sebastian, S.(16);Moran, G.W.(17);Lightner, A.(18);Wong, S.Y.(19);Cohen, B.L.(20);Holubar, S.(21);Ding, N.S.(22);Behrenbruch , C.(23);Kapil, S.(3);Misra , R.(1);Lung, P.(24);Hart, A.(1);Tozer, P.(3);
(1)St. Mark@E@s Hospital, Gastroenterology, London, United Kingdom;(2)School of Clinical Medicine- St Vincent’s Healthcare Clinical Campus- University of New South Wales, Gastroenterology, Sydney, Australia;(3)St. Mark@E@s Hospital, Colorectal Surgery, London, United Kingdom;(4)University Hospital Ghent, Gastroenterology, Ghent, Belgium;(5)Hôpital du Sacré-Coeur de Montréal, Gastroenterology, Montreal, Canada;(6)Aarhus University Hospital, Gastroenterology, Aarhus, Denmark;(7)Aarhus University Hospital, Colorectal Surgery, Aarhus, Denmark;(8)University Hospitals of Leuven, Colorectal Surgery, Leuven, Belgium;(9)University Hospitals of Leuven, Gastroenterology, Leuven, Belgium;(10)University Hospital Ghent, Colorectal Surgery, Ghent, Belgium;(11)University Hospital Ghent, Radiology, Ghent, Belgium;(12)Humanitas Research Hospital, Colorectal Surgery, Milan, Italy;(13)Humanitas Research Hospital, Gastroenterology, Milan, Italy;(14)Amsterdam UMC- location AMC, Colorectal Surgery, Amsterdam, The Netherlands;(15)Amsterdam UMC- location AMC, Gastroenterology, Amsterdam, The Netherlands;(16)Hull University Teaching Hospitals, Gastroenterology, Hull, United Kingdom;(17)Nottingham University Hospitals, Gastroenterology, Nottingham, United Kingdom;(18)Scripps Clinic, Colorectal Surgery, San Diego, United States;(19)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(20)Cleveland Clinic, Gastroenterology, Ohio, United States;(21)Cleveland Clinic, Colorectal Surgery, Ohio, United States;(22)St. Vincent’s Hospital, Gastroenterology, Melbourne, Australia;(23)St. Vincent’s Hospital, Colorectal Surgery, Melbourne, Australia;(24)St. Mark@E@s Hospital, Radiology, London, United Kingdom;On behalf of the TOpCLASS perianal Crohn@E@s disease Consortium.
P936: Ultrasound Transmural Remission in Crohn@E@s disease: Different Rate between First and Second Line of Biological TherapyECCO'24Year: 2024
Authors: De Sire, R.(1)*;Rispo, A.(1);Caiazzo, A.(1);Cantisani, N.(1);Calabrese, G.(1);Guarino, A.(1);Testa, A.(1);Nardone, O.M.(1);Castiglione, F.(1);
(1)University Federico II of Naples, IBD Unit- Department of Clinical Medicine and Surgery, Naples, Italy;
P937: A Retropective Analysis of Micronutrient Status in Inflammatory Bowel DiseaseECCO'24Year: 2024
Authors: Ruan, G.(1)*;Zhang, Y.(1);Yu, S.(2);Yang, H.(1);
(1)Peking Union Medical College Hospital- Peking Union Medical College & Chinese Academy of Medical Sciences, Department of Gastroenterology, Beijing, China;(2)Peking Union Medical College Hospital- Peking Union Medical College & Chinese Academy of Medical Sciences, Department of Clinical Laboratory, Beijing, China;
P938: Effectiveness and safety of switching from original infliximab to GP1111 biosimilar in inflammatory bowel diseases – prospective, cohort studyECCO'24Year: 2024
Authors: Resál, T.(1)*;Bacsur, P.(1);Pápista, M.(1);Kata, D.(2);Farkas, B.(1);Bálint, A.(1);Fábián, A.(1);Bor, R.(1);Szepes, Z.(1);Farkas, K.(1);Molnár, T.(1);
(1)University of Szeged, Department of Medicine, Szeged, Hungary;(2)University of Szeged, Institution of Laboratory Medicine, Szeged, Hungary;
P939: Ozanimod-Exposed Patients with Ulcerative Colitis Undergoing Total Colectomy Exhibit Unique Histologic Changes in Lymph NodesECCO'24Year: 2024
Authors: Cohen, N.A.(1)*;Weber, C.(2);Cheng, J.(2);Choi, D.(1);Garcia, N.(1);Choi, N.(1);Rubin, D.(1);
(1)University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States;(2)University of Chicago Medicine, Department of Pathology, Chicago, United States;
P940: A glance into paediatric Inflammatory Bowel Disease in Australasia – Crohn’s Colitis Cure (CCC) data insights programECCO'24Year: 2024
Authors: Pipicella, J.L.(1,2,3)*;Dutt, S.(4,5);Giles, E.(6,7);Day, A.S.(8);Wright, R.(9);Goodfellow, T.(10);William, W.(11,12);Andrews, J.M.(2,13,14);Connor, S.J.(1,2,3,15);
(1)University of New South Wales, Medicine & Health South Western Sydney Clinical School, Warwick Farm, Australia;(2)Crohn@E@s Colitis Cure, CCCure, Pyrmont, Australia;(3)Ingham Institute for Applied Medical Research, Gastroenterology- Hepatology and Inflammatory Bowel Disease Research Group, Liverpool, Australia;(4)The Children’s Hospital at Westmead, Department of Gastroenterology, Westmead, Australia;(5)The University of Sydney, Children’s Hospital Westmead Clinical School, Sydney, Australia;(6)Monash University, Department of Paediatrics, Clayton, Australia;(7)Hudson Institute of Medical Research, Centre for Innate Immunity and Infectious Disease, Clayton, Australia;(8)University of Otago Christchurch, Department of Paediatrics, Christchurch, New Zealand;(9)Department of Paediatrics, University of Otago, Christchurch, New Zealand;(10)SA Health, Department of Health and Wellbeing- Office of the Chief Medical Information Officer, Adelaide, New Zealand;(11)Lyell McEwin Hospital, Anaesthetics, Adelaide, Australia;(12)SA Health, Chief Medical Information Officer, Adelaide, Australia;(13)Central Adelaide Local Health Network, Gastroenterology, Adelaide, Australia;(14)The University of Adelaide, Faculty of Health Sciences, Adelaide, Australia;(15)Liverpool Hospital, Gastroenterology and Hepatology, Liverpool, Australia;
P941: Observational study of tofacitinib in ulcerative colitis in Sweden (ODEN) – Interim analysis of clinical and biomarker dataECCO'24Year: 2024
Authors: Nyberg, L.(1,2);Söderling, J.(3);Olén, O.(3);Strid, H.(4);Jäghult, S.(5);Halfvarson, J.(6);Hedin, C.(7);Jónsdóttir, S.(4);Hjortswang, H.(8);Cappelleri, J.(9);Henrohn, D.(10,11);Seddighzadeh, M.(10);Marsal, J.(2,12);Grip, O.(12)*;
(1)Skåne University Hospital, Department of Gastroentrology, Malmö, Sweden;(2)Lund University, Department of Clinical Sciences, Lund, Sweden;(3)Karolinska Institutet, Clinical Epidemiology, Stockholm, Sweden;(4)Karolinska University Hospital, Department of Gastroenterology, Stockholm, Sweden;(5)Karolinska Institutet, Department of Clinical Sciences, Stockholm, Sweden;(6)Örebro University, Institute of Medical Sciences, Örebro, Sweden;(7)Karolinska institutet, Department of Medicine, Stockholm, Sweden;(8)University of Linköping, Department of Clinical and Experimental Medicine, Linköping, Sweden;(9)Pfizer Inc, Statistical Research and Data Science Center, Groton- Connecticut, United States;(10)Pfizer AB, Department of Medical Affairs, Stockholm, Sweden;(11)University of Uppsala, Department of Medical Sciences, Uppsala, Sweden;(12)Skane University Hospital, Department of Gastroenterology, Lund/Malmö, Sweden;SWIBRED ODEN Study group
P942: Real-world data on outcomes of treatment with ustekinumab in patients with Ulcerative ColitisECCO'24Year: 2024
Authors: Chalakatevaki, K.(1)*;Kokkotis, G.(1);Chatzinikolaou, M.L.(1);Anagnostopoulou, E.(2);Argiriou, K.(3);Viazis, N.(4);Galanopoulos, M.(5);Gerasimatos, G.(6);Giouleme, O.(7);Zampeli, E.(8);Zacharopoulou, E.(9);Theodoropoulou, A.(10);Theocharis, G.(11);Kalogirou, M.(7);Karatzas, P.(12);Karmiris, K.(10);Kapsoritakis, A.(3);Koustenis, K.(4);Koutroumpakis, I.(13);Kiriakos, N.(5);Lazou, D.(14);Liatsos, C.(5);Mantaka, A.(2);Mantzaris, G.(4);Michalopoulos, G.(6);Michopoulos, S.(8);Orfanidou, A.(12);Papathanasiou, E.(8);Polymeros, D.(15);Potamianos, S.(3);Sotiropoulos, C.(11);Soufleris, K.(14);Tzouvala, M.(9);Foteinogiannopoulou, K.(13);Chatzidakis, A.(15);Psistakis, A.(10);Bamias, G.(1);
(1)3rd Academic Department of Internal Medicine, University of Athens- Sotiria Hospital- GI Unit, Athens, Greece;(2)Saint George General Hospital of Chania, Department of Gastroenterology, Chania- Crete, Greece;(3)University General Hospital of Larissa, Department of Gastroenterology, Larissa, Greece;(4)Evangelismos Hospital, Department of Gastroenterology, Athens, Greece;(5)401 General Military Hospital, Department of Gastroenterology, Athens, Greece;(6)General Hospital G. Gennimatas, Department of Gastroenterology, Athens, Greece;(7)Aristotle University of Thessaloniki, 2nd Propedeutic Department of Internal Medicine, Thessaloniki, Greece;(8)General Hospital Alexandra, Department of Gastroenterology, Athens, Greece;(9)General Hospital of Nikea and Pireaus, Department of Gastroenterology, Athens, Greece;(10)Venizeleio General Hospital, Department of Gastroenterology, Heraklion- Crete, Greece;(11)General University Hospital of Patras, Department of Gastroenterology, Patras, Greece;(12)General Hospital Laiko, Department of Gastroenterology, Athens, Greece;(13)University General Hospital of Heraklion, Department of Gastroenterology, Heraklion- Crete, Greece;(14)Theagenio Cancer Hospital of Thessaloniki, Department of Gastroenterology, Thessaloniki, Greece;(15)Attikon University Hospital, Department of Gastroenterology, Athens, Greece;
P943: Real world Effectiveness and safety of tofacitinib in patients with Ulcerative Colitis: 6 months follow-up of the French TOFAST studyECCO'24Year: 2024
Authors: Fumery, M.(1)*;Bouhnik, Y.(2);Faure, P.(3);Bouzidi, A.(4);Brault, Y.(5);Peyrin-Boroulet, L.(6);Laharie, D.(7);
(1)University Hospital of Amiens, Gastroenterology and Hepatology Unit, Amiens, France;(2)Clinique Ambroise-Paré, Institut des MICI-, Neuilly-Sur-Seine, France;(3)Clinique Pasteur, Gastroenterology, Toulouse, France;(4)Pfizer France, Immunologie and Inflammation, Paris, France;(5)Pfizer France, Inflammation and Immunology, Paris, France;(6)IHU Infinity, IBD Unit, Nancy, France;(7)University hopital of Bordeaux, Gastroenterology and Hepatology Unit, Bordeaux, France;
P944: Ustekinumab in refractory Ulcerative Colitis: single-center, real-world experienceECCO'24Year: 2024
Authors: Herrera De Guise, C.M.(1)*;Mayorga Ayala, L.F.(1);Robles Alonso, V.(1);Serra Ruiz, X.(1);Céspedes Martínez, E.(1);Lastiri Gonzalez, E.(1);Pérez Martínez, Z.(1);Oller Jimenez, E.(1);Casellas, F.(1);Borruel Sainz, N.(1);
(1)Unitat d@E@Atenció Crohn-Colitis- Hospital Universitari Vall d@E@Hebron, Gastroenterology, Barcelona, Spain;
P945: Crohn´s disease response to ustekinumab measured by bowel ultrasoundECCO'24Year: 2024
Authors: Navarro-Gerrard, C.(1);Bastón Rey, I.(1)*;González López, J.(2);Ferreiro Iglesias, R.(1);Sequeiros Portela, M.D.(1);Dominguez Munoz, J.E.(1);Barreiro de Acosta, M.(1);
(1)University Hospital Santiago de Compostela CHUS, Gastroenterology, Santiago de Compostela, Spain;(2)University Hospital Santiago de Compostela CHUS, Pharmacy, Santiago de Compostela, Spain;
